Stockwatch > News > News Item


			Nucryst Pharmaceuticals Corp
			Symbol			NCS
			Shares Issued			18,325,365
			Close 2009-07-10			C$ 0.47
			Recent Sedar Documents

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Nucryst to release Q2 2009 results Aug. 5

2009-07-21 17:01 ET - News Release

Mr. David Wills reports

NUCRYST PHARMACEUTICALS CORP. CONFERENCE CALL TO DISCUSS 2009 SECOND QUARTER RESULTS

Nucryst Pharmaceuticals Corp. invites analysts and investors to participate in a briefing on Wednesday, Aug. 5, 2009, with David Holtz, interim president chief executive officer, and chief financial officer, regarding the company's 2009 second quarter results. The briefing, via conference call, is set for 9 a.m. ET. To participate, please call the toll-free number 1-800-731-5774. In addition to standard disclosure over wire services, a news release with the second quarter results will be posted on the Nucryst website prior to the call. The call will also be broadcasted live on the Internet on the company's website.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Nucryst to release Q2 2009 results Aug. 5

The remainder is available to Stockwatch subscribers. If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.